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To characterize Babesia bovis merozoite antigens that stimulate anamnestic T helper (Th)-cell responses
from B. bovis-immune cattle, B. bovis-specific Th-cell lines and clones, previously assigned to different antigenic
groups (W. C. Brown, S. Zhao, A. C. Rice-Ficht, K. S. Logan, and V. M. Woods, Infect. Immun. 60:4364–4372,
1992), were tested in proliferation assays against fractionated merozoite antigens. The antigenic groups were
determined by the patterns of response of Th clones to different parasite isolates and soluble or membrane
forms of merozoite antigen. Soluble antigen fractionated by anion-exchange chromatography or gel filtration
by using fast-performance liquid chromatography resolved two or three antigenic peaks, respectively. To enable
fractionation of membrane-associated proteins and to resolve more precisely the proteins present in homog-
enized merozoites, a novel technique of continuous-flow electrophoresis was employed. Merozoite membranes
or whole merozoites were homogenized and solubilized in sodium dodecyl sulfate-sample buffer, electropho-
resed under reducing conditions on 15% or 10% acrylamide gels, eluted, and collected as fractions. Individual
fractions were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and tested for the ability
to stimulate Babesia-specific CD41 T-cell lines and clones. CD41 Th-cell lines from two cattle displayed
differential patterns of reactivity and detected numerous peaks of antigenic activity, ranging from <14 to 76
kDa. Th-cell clones previously categorized into different antigenic groups detected antigenic peaks unique for
clones representative of a given group. Antigens of 29, 51 to 52, and 85 to 95 kDa (group I), 40 kDa (group III),
20 kDa (group IV), 58 to 60 kDa (group VI), and 38, 45, and 83 kDa (group VII) were identified in the
stimulatory fractions. Immunization of rabbits with selected fractions produced a panel of antisera that
reacted specifically on Western blots (immunoblots) with merozoite antigens of similar sizes, leading to the
tentative identification of candidate antigens of B. bovis merozoites with molecular masses of 20, 40, 44, 51 to
52 or 95, and 58 to 60 kDa that stimulate proliferation of Th clones representative of five different antigenic
groups. These antisera may be useful for isolating recombinant proteins that are immunogenic for Th cells of
immune cattle and therefore potentially useful for vaccine development.
Babesia bovis is an economically important hemoprotozoan
parasite of cattle that is endemic in many tropical and subtrop-
ical regions of the world, including eastern, southern, and
central Africa, Australia, and Central and South America.
Babesiosis results in high mortality rates among susceptible
cattle or the presence of a carrier state in recovered cattle.
Control of B. bovis has proven difficult since it is widespread,
endemic in wild ruminant populations, transmitted by ticks
(Boophilus spp.), and capable of inducing a chronic carrier
state. Despite decades of research, safe and effective vaccines
for this and related protozoan parasites, including the human
parasites Babesia microti (39), a newly recognized pathogenic
Babesia sp. (44), and Plasmodium spp. (28), are still lacking.
Although the nature of acquired resistance to B. bovis has
not been defined clearly (8), it is well established that CD41 T
cells and activated macrophages are important for protective
immunity against related babesial and malaria infections of
mice (14, 27, 28, 40, 49). In murine malaria, both subsets of T
helper (Th) cells appear to be important for immunity, with
Th1 cells (producing gamma interferon [IFN-g], tumor necro-
sis factor beta, and interleukin-2 [IL-2]) appearing early and
Th2 cells (producing IL-4, IL-5, IL-6, and IL-10) appearing
late in infection (27). Cytokines produced by Th2 cells likely
function to maintain antiparasitic antibody titers once the ini-
tial infection has been controlled by cell-mediated immune
mechanisms (27).
The acquired protective immune response to B. bovis in
cattle depends most likely on both cell-mediated and humoral
mechanisms. Cattle that recover from infection with B. bovis,
either naturally or following chemotherapy with antiparasitic
drugs, develop long-lived protective immunity against subse-
quent exposure to homologous and some heterologous strains
(30, 32, 33). Both high antibody titers (50) and cell-mediated
immune responses, determined by in vitro proliferation assays
of peripheral blood mononuclear cells (PBMC), were observed
in cattle immune to challenge (6, 46). Mahoney and coworkers
(30) found that passively transferred hyperimmune serum or
mixtures of immunoglobulins G1 and G2 effectively lowered
parasitemias in splenectomized calves infected 4 days earlier.
However, the protective effect was observed only for homolo-
gous parasite strains. These results were in contrast to the
observation that crude parasite extracts conferred protection
against both homologous and heterologous strains (31) and
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suggested that the antigenic determinants that induced cross-
protective immunity differed from those that induced anti-
body-mediated immunity observed in the passive transfer stud-
ies. Furthermore, serologically immunodominant antigens
present in protective fractions of merozoites were not protec-
tive (20, 45, 48, 50, 51). These findings, together with the
well-documented role of T cells in other protozoan infections
(28, 41), indicated the need to identify protein antigens and
their epitopes that induce cell-mediated immune responses
against B. bovis. Therefore, our laboratory has focused on
characterizing T-cell responses and T-cell-dependent antigens
of B. bovismerozoites as a strategy for developing vaccines that
would incorporate T-cell epitopes important in the induction
of a protective immune response (12, 13).
B. bovis preferentially induces the proliferation of CD41 Th
cells in short-term cultures of PBMC stimulated with crude
membrane (CM) or soluble, cytosolic high-speed supernatant
(HSS) antigen prepared from homogenized merozoites (5).
Because this parasite does not possess an exoerythrocytic stage
that could serve as a target for major histocompatibility com-
plex (MHC)-restricted cytotoxic T cells, we have concentrated
our studies on characterizing Th cells. Cytokine analysis of
Th-cell clones derived from the CD41 T-cell lines showed that
merozoite antigens preferentially induced Th0- and Th1-like
cells that produced the high titers of IFN-g required for acti-
vation of antiparasitic properties of macrophages (11, 12). Pro-
liferation assays with a panel of CD41 T-cell clones revealed a
differential pattern of response to soluble HSS antigen, mem-
brane-enriched CM antigen, detergent extracts of the mem-
brane form of antigen, culture supernatant exoantigen (EXO),
and different geographical isolates of B. bovis as well as Babesia
bigemina parasites. The patterns of response by the Th clones
indicated the presence of at least five different antigenic
epitopes in the merozoite extracts, and the Th clones were
assigned correspondingly to one of five antigenic groups (12).
Application of gel filtration techniques to separate soluble
merozoite antigen revealed the presence of additional anti-
genic groups, described in the current study, and increased the
number of antigenic groups to seven (reviewed in reference 8).
Fractionation of the soluble, cytosolic HSS antigen by anion-
exchange chromatography or gel filtration revealed only two or
three different antigenic peaks and indicated the need for
alternative protein separation techniques.
Fractionation of Plasmodium chabaudi adami schizont pro-
teins by continuous-flow electrophoresis (CFE) identified pro-
tective antigens in the molecular mass range of 25 to 40 kDa
(25). Since T cells are required for and have been shown to
confer protective immunity in this murine model (1, 21), this
finding suggested that protective T-cell antigens could be de-
fined by this technique. Using a similar procedure that is de-
scribed in the present study, we have identified candidate pro-
tein antigens of B. bovis merozoites with molecular masses of
20, 40, 44, 51 to 52 or 95, and 58 to 60 kDa that stimulate
proliferation of Th-cell clones representative of five of the
seven different antigenic groups. Antisera raised against im-
munostimulatory fractions recognized bands on Western blots
(immunoblots) of whole merozoite extracts that corresponded
in molecular mass to antigens identified in the fractions. These
antisera will be employed to screen a B. bovis expression library
to isolate recombinant proteins capable of activating poten-
tially protective Th cells.
MATERIALS AND METHODS
Babesial parasite strains and cultivation. The Mexico strain of B. bovis was
isolated originally in 1978 from cattle infected with natural, tick-derived isolates
from a Babesia-endemic area of Mexico (6). The Texas strain of B. bovis was
obtained in 1978 from an infected animal in southern Texas (37) and was
provided by Will Goff (USDA Agricultural Research Service, Pullman, Wash.).
The Australian L strain of B. bovis was isolated in 1965 from an infected animal
in New South Wales, Australia (31), and was provided by Stephen Hines (Wash-
ington State University, Pullman). The Mexico strain of B. bigemina was obtained
in 1982 from an infected animal in northeastern Mexico (6). In vitro mi-
croaerophilous cultures of all babesial strains were maintained in bovine eryth-
rocytes (6).
Experimental cattle. Animal C15 was inoculated intravenously four times over
the course of 6 years with cultured, autologous infected erythrocytes. The final
inoculation of 109 parasitized erythrocytes did not evoke a fever or a reduction
in packed erythrocyte cell volume. Animal C97 was infected by infestation with
Boophilus microplus tick larvae infected with the same strain of B. bovis. The
animal recovered from clinical babesiosis following treatment with 3 mg of
diaminazine aceturate per kg of body weight and was solidly immune to chal-
lenge infection 3 months later with an intramuscular inoculation of a virulent,
infected tick stabilate. A Babesia-naive control animal used to assess the viru-
lence of the stabilate became clinically ill, experiencing a 57% reduction in
packed erythrocyte cell volume on day 14 postchallenge (6).
Parasite antigens. A homogenate (H) was prepared with a French pressure
cell (SLM Instruments, Inc., Urbana, Ill.) as described previously (6) from
culture-derived B. bovis or B. bigemina merozoites suspended in phosphate-
buffered saline (PBS; pH 7.2) or double-distilled and deionized H2O containing
the protease inhibitors (Boehringer Mannheim Biochemicals, Indianapolis, Ind.)
E-64 (25 mg/ml), antipain (25 mg/ml), and phenylmethylsulfonyl fluoride (2 mM).
Ultracentrifugation of the homogenized parasites yielded a soluble, cytosolic
HSS fraction and a fraction enriched in CM as described previously (6). Unin-
fected erythrocytes (URBC) were prepared similarly for use as control antigens.
Supernatants containing parasite EXO were collected from cultures of B. bovis
Mexico-infected erythrocytes and assessed for antigenic activity.
Fractionation of HSS antigen by anion-exchange chromatography. Soluble
merozoite HSS was fractionated by anion exchange on a Mono Q (HR 5/5)
column with a fast-performance liquid chromatography (FPLC) apparatus
(Pharmacia LKB Biotechnology, Piscataway, N.J.) as described previously (12).
HSS was prepared in H2O, adjusted to a concentration of 20 mM HEPES
(N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid; starting buffer), and fil-
tered, and 4.5 mg of protein was applied to the Mono Q column. Proteins were
eluted with a 20-ml linear NaCl gradient of 0.0 to 1.0 M NaCl in 20 mM HEPES
at a flow rate of 1.0 ml/min, and protein was monitored at 280 nm. Individual
1.0-ml fractions were collected, filter sterilized, diluted to isotonicity (150 mM
NaCl), and stored at 2808C for T-cell proliferation studies. We determined
previously that 25% (vol/vol) of each fraction induced optimal proliferation of T
cells (12).
Fractionation of HSS antigen by gel filtration. Soluble merozoite HSS was
fractionated by gel filtration on a Superose 12 column with FPLC (Pharmacia).
HSS was prepared in PBS and concentrated on a Centricon 10 membrane
(Amicon, Danvers, Mass.), and 200 ml of sample containing approximately 1.9
mg of protein was applied to the column. Proteins were eluted with PBS at a flow
rate of 0.4 ml/min. Individual 0.4-ml fractions were collected and stored at2808C
for T-cell proliferation assays; they were subsequently used at a final volume of
25% in the assay wells. The column was calibrated with molecular mass standards
(Pharmacia) that included aldolase (158 kDa), bovine serum albumin (66 kDa),
and chymotrypsin (25 kDa).
Fractionation of CM or merozoite H by CFE. CFE of merozoite antigen was
performed with a Prep-Cell Apparatus (Bio-Rad Laboratories, Richmond, Ca-
lif.). Approximately 10 to 15 mg of B. bovis CM or H was solubilized in sodium
dodecyl sulfate (SDS)-sample buffer containing b-2-mercaptoethanol, boiled,
electrophoresed under reducing conditions on 28-mm (internal diameter) cylin-
drical gels consisting of either 15 or 10% acrylamide, eluted, and collected
(2.5-ml fractions) over the course of 8.5 h (15% acrylamide gel; 110 fractions) or
24 h (10% acrylamide gels; 220 to 240 fractions). The fractions were stored at
2808C. An aliquot of every 10th fraction was analyzed on silver-stained SDS-
polyacrylamide gels. A 1.0- or 1.5-ml aliquot of each fraction was then processed
for proliferation assays as described by Kima et al. (25) with the following
modifications. For each experiment, a constant volume of fraction was mixed
with 8 volumes of ice-cold acetone, placed in a dry ice-ethanol bath for 30 min,
and centrifuged at 10,000 3 g for 30 min. The acetone was aspirated, the
precipitates were resuspended in 70% ethanol and centrifuged at 10,000 3 g for
30 min, and the ethanol was aspirated. The pellets were air dried, suspended in
250 ml of PBS, aliquoted, and stored at 2808C. To examine the potential toxic
effects of residual SDS or other gel components on T-cell proliferation, the
ability of individual fractions to affect mitogen-induced proliferation of PBMC
was determined. PBMC (2 3 105) were cultured in replicate wells with 2.5 mg of
concanavalin A (Sigma) per ml and serial dilutions of the reconstituted fractions.
It was found that addition of the fractions to a final concentration of 12.5%
(vol/vol) had no deleterious effect on the proliferative response to concanavalin
A. Subsequent experiments therefore used either 12.5 or 6.2% (vol/vol) of each
fraction in the assay wells. A third aliquot of selected fractions was used for the
production of rabbit antisera.
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Protein determination. Protein concentrations in subcellular and biochemi-
cally separated parasite fractions were determined by the Bradford protein assay
(Bio-Rad) with bovine immunoglobulin as a protein standard.
SDS-PAGE analysis of fractionated merozoite antigens. SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) was carried out with a minigel system (Bio-
Rad) and 12% acrylamide gels (26). Molecular mass standards and silver stain
were obtained from Bio-Rad. Equal volumes (16 ml) of the column flowthrough
and selected fractions (1 to 14) of HSS separated by FPLC Mono Q column
chromatography and unfractionated HSS (12.5 mg of protein) were diluted with
sample buffer and electrophoresed under reducing conditions. Similarly, to an-
alyze CFE fractions eluted from the 15% acrylamide gel, 30 ml of every 10th
fraction was analyzed by SDS-PAGE in 12% acrylamide gels. For CFE fractions
eluted from 10% acrylamide gels, 37.5 ml of every 10th fraction was analyzed by
SDS-PAGE with 4 to 20% acrylamide gradient gels.
B. bovis-specific T-cell lines and clones. B. bovis-specific T-cell lines were
established approximately 1.5 years (animal C15) and 4 years (animal C97)
following the last challenge inoculation with the Mexico isolate of B. bovis. To
establish cell lines, 4 3 106 PBMC were cultured in 24-well plates (Costar) in a
final volume of 1.5 ml of complete RPMI 1640 medium with 25 mg of B. bovis
Mexico CM antigen per ml (5). At weekly intervals thereafter for 7 weeks, the
proliferating T lymphocytes were subcultured to a density of 3.3 3 105 cells per
ml with antigen and 2 3 106 irradiated (3,000 rads) autologous PBMC as a
source of antigen-presenting cells (APC). When examined after 4 weeks of
culture, the C15 T-cell line contained 87% CD41 T cells, 5% CD81 T cells, and
7% g/d TcR11 T cells, and the C97 T-cell line contained 98% CD41 cells.
The derivation of Th-cell clones from B. bovis-immune animals C15 and C97
that were used in this study was described in previous publications (11, 12). All
of the clones are B. bovis specific, CD41, and MHC class II restricted. A
differential pattern of response by the Th clones to different parasite antigens
resulted in assigning individual clones to an antigenic group. A total of seven
antigenic groups have been defined in this manner (8), and clones representative
of five of those groups (I, III, IV, V, and VII) were used in this study (Table 1).
Cell surface phenotypic analysis. B. bovis-specific T-cell lines were stained
with a panel of monoclonal antibodies by indirect immunofluorescence as de-
scribed previously (3) and analyzed with a Coulter EPICS 741 flow cytometer.
Monoclonal antibodies specific for bovine leukocyte surface markers obtained
from the International Laboratory for Research on Animal Diseases (Nairobi,
Kenya) included IL-A51, specific for CD8, IL-A12, specific for CD4, and IL-A26,
specific for CD2. Monoclonal antibody CACT-61A, specific for the g/d TCR1-
N12 determinant, was kindly provided by Bill Davis, Washington State Univer-
sity, Pullman.
Lymphocyte proliferation assays. Proliferation assays were carried out in du-
plicate wells of half-area 96-well plates (Costar) at 378C in a humidified atmo-
sphere of 5% CO2 in air for 3 days as described previously (12). Each well (total
volume, 100 ml) contained complete RPMI 1640 medium, responder cells added
at a final concentration of 33 105 cells per ml (obtained 6 or 7 days following the
last stimulation of the T-cell lines or clones with antigen), and 23 106 autologous
or allogeneic, irradiated (3,000 rads) PBMC per ml as a source of APC. B. bovis
CM and URBC antigens were added to the assay mixes at a final concentration
of 25 mg of protein per ml of complete medium. Fractionated antigens were
included at a final concentration of 6.25 to 25% (vol/vol). In some experiments,
the Th clones were assayed with the addition of either 1 to 5 U of human
recombinant IL-2 (Boehringer Mannheim Biochemicals) per ml or 2% (vol/vol)
bovine T-cell growth factor (TCGF [4]), in addition to antigen, to all wells of the
proliferation assays. Proliferation was determined by measuring the incorpora-
tion of 0.25 mCi of [125I]iododeoxyuridine (ICN Radiochemicals, Inc., Costa
Mesa, Calif.) added during the final 4 h of the assay. The cells were harvested,
and the radioactivity was counted in a gamma counter. Results are presented as
the mean counts per minute (cpm) and standard deviation (SD) of duplicate
samples.
Production of rabbit antisera against selected CFE fractions and immunoblot
analysis. Selected fractions obtained with CFE with 10% acrylamide gels that
contained antigenic activity for different Th-cell clones were used to immunize
rabbits for the production of antisera. In experiment 1, fractions 1, 11, 30 plus 31,
and 60 plus 61 were selected, and in experiment 2, fractions 40, 59, and 100 were
selected. Fractions 1, 11, 30 plus 31, and 60 plus 61 were concentrated by
Centricon 10 filtration, and a total of 40 to 120 mg of protein was emulsified in
RIBI adjuvant (MPL 1 TDM 1 CWS Emulsion, R-730; RIBI ImmunoChem
Research, Inc., Hamilton, Mont.) and injected three times at 3- to 4-week
intervals as suggested by the manufacturer. For fractions 40, 59, and 100, 1.5 ml
of each original fraction was emulsified in an equal volume of RIBI adjuvant and
divided into three inoculations, 3 to 4 weeks apart. The rabbits were exsangui-
nated 6 to 7 days following the final immunization, and the sera were absorbed
extensively with membranes prepared from URBC. Preimmunization and
postimmunization sera were tested for reactivity against homogenized B. bovis
merozoites or URBC by immunoblotting as described previously (43). Briefly, 15
mg of B. bovis or 20 mg of URBC antigen was resolved by SDS-PAGE in 12%
acrylamide gels and transferred electrophoretically to nitrocellulose membranes.
Pre- or postimmunization rabbit sera were used to develop the immunoblots.
Nitrocellulose membranes to which protein was bound were incubated in a PBS
blocking solution with 5% nonfat dry milk and 0.02% sodium azide for 1 h at
room temperature. The membranes were incubated for 1 to 2 h at 48C in
blocking solution containing rabbit sera diluted 1:400 to 1:1,600. The filters were
washed extensively and incubated for 1 h at room temperature with alkaline
phosphatase-conjugated goat anti-rabbit immunoglobulin G (heavy plus light
chain; Kirkegaard & Perry Laboratories, Gaithersburg, Md.) diluted 1:2,000 in
blocking solution. The membranes were again washed, and the chromagenic
substrates nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate (Sig-
ma) were used at a concentration of 50 mg/ml in Tris-buffered saline and added
to the membranes to detect bound antibodies.
RESULTS
Characterization of the Th clones used in this study. Previ-
ous studies in our laboratory to date have revealed that B. bovis
merozoites contain at least seven different epitopes immuno-
genic for T cells (8, 12). These distinctions were based on the
differential patterns of proliferative responses of T-cell lines
enriched for CD41 T cells and Th-cell clones to different
parasite isolates and to fractions of merozoite antigen (H, CM,
HSS, and EXO). The antigen profiles of the clones used in the
current study are summarized in Table 1. Th clones in group I
reacted with the CM antigen only and recognized all isolates of
B. bovis tested but not B. bigemina. The remaining Th clones
TABLE 1. Characterization of B. bovis-specific Th-cell clones used in this study
Th-cell clone
Responsea to the following antigens:
Reference(s)
Parasite isolatesb Unfractionated B. bovis antigenc
B. bovis B. bigemina
Mexico H CM EXO HSSMexico Texas Australia
Group I
C97.2D2 1 1 1 2 1 1 6 2 12
C97.2E4 1 1 1 2 1 1 6 2 12
Group III
C97.3C3 1 1 1 1 1 1 2 1 12
C15.1E3 1 1 1 1 1 1 2 1 11
C15.2G10 1 1 1 1 1 1 2 1 11
Group IV: C15.1H6 1 1 1 2 1 1 2 1 11, 12
Group V: C15.1D10 1 1 1 2 1 1 2 1 11
Group VII: C15.2D7 1 1 2 2 1 1 1 1 11, 12
a Proliferative responses of the individual Th clones in each of the antigenic groups listed are indicated as follows: 1, positive response; 6, weakly positive response;
and 2, negative response.
b B. bovis isolates were obtained from Mexico, Texas, and Australia, and the B. bigemina isolate was obtained from Mexico.
c B. bovis H, CM, EXO, and HSS were prepared from merozoites of the Mexico isolate.
3108 BROWN ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
proliferated in response to soluble HSS antigen in addition to
CM antigen (groups III to VII). Clones in group VII, unlike
the others, responded strongly to the culture supernatant
EXO. Other clones were grouped by the soluble antigen frac-
tionation pattern and response to Australia parasites and B.
bigemina.
Fractionation of soluble HSS antigen by anion-exchange
chromatography. Previous fractionation of HSS antigen by
anion-exchange chromatography identified two antigenic
peaks that induced proliferation of a panel of five clones (12).
Clone C97.3C3 (group III) responded to fractions eluted with
0.25 M NaCl, whereas the remaining clones, including clones
C15.1H6 (group IV) and C15.2D7 (group VII), responded to
fractions eluted with 0.35 to 0.45 M NaCl. In the current study,
clone C97.3C3, C15.1E3, and C15.2G10 (group III) recognized
antigen in fractions 10 and 11 that eluted with 0.2 to 0.25 M
NaCl from the Mono Q column (Fig. 1). Furthermore, cells
from all three clones proliferated against HSS antigens present
in fractions 2 to 9, which represented material that was not
bound by the column during a wash step. Maximum prolifer-
ation of all three clones was obtained with fractions 2 and 3.
There was no antigenic activity present in the column flow-
through (data not shown). Proteins present in the flowthrough
and stimulatory and nonstimulatory fractions (1 to 14) were
analyzed by SDS-PAGE to determine if any bands common to
the stimulatory fractions could be identified (Fig. 2). A single
faint band with an apparent molecular mass of 43 kDa com-
mon to fractions 2, 3, 10, and 11 was visualized. These results
are consistent with our hypothesis that the three clones previ-
ously assigned to antigenic group III recognize the same anti-
gen. The stimulatory protein is poorly reactive with the anion-
exchange matrix and appears to have a molecular mass of 43
kDa, although the presence of additional immunostimulatory
proteins in these fractions cannot be excluded.
Fractionation of soluble HSS antigen by gel filtration. To
further characterize the proteins present in soluble HSS, gel
filtration was performed by FPLC, and fractions were tested
against HSS-reactive clones in antigenic groups III, IV, and V.
Three distinct peaks of antigenic activity that stimulated pro-
liferation of clones from the three different antigenic groups
were detected (Fig. 3). Activity for clone C15.2G10 (group III)
eluted in a broad peak ranging from 30 to 70 kDa as did activity
for additional group III clones C97.3C3 and C15.1E3 (data not
shown). Clone C15.1H6 (group IV) recognized an antigenic
peak that corresponded to the 25-kDa molecular mass marker,
and clone C15.1D10 (group V) recognized a major antigenic
FIG. 1. Proliferative responses of three Th cell clones in antigenic group III
to B. bovisMexico HSS antigen fractionated by anion-exchange chromatography
with FPLC. HSS was applied to the Mono Q column, the column was washed,
and the proteins were eluted with a linear NaCl gradient (diagonal line) and
monitored for protein at 280 nm (wavy line) on a scale of 0 (baseline) to 1.0
(maximum peaks) U of absorbance. Fractions were diluted to isotonicity, and
25-ml samples were assayed in duplicate cultures with autologous APC and the
following Th-cell clones: C97.3C3 (plus 2 U of human IL-2 per ml), C15.1E3, and
C15.2G10. The symbols indicate the proliferative responses to individual frac-
tions. The mean 6 SD background proliferative response of clone C97.3C3
cultured with medium plus IL-2 was 2,727 6 1,593 cpm, which was subtracted
from the mean cpm obtained from individual fractions. The mean 6 SD back-
ground proliferative responses of clones C15.1E3 and C15.2G10 cultured with
medium were 201 6 43 cpm and 136 6 7 cpm, respectively.
FIG. 2. Selected anion-exchange fractions resolved by SDS-PAGE and silver
stained. Unfractionated HSS (12.5 mg of protein) and 16 ml of the column
flowthrough (FT) or fractions 1 to 14 were electrophoresed. The relative mobil-
ities of molecular mass standards (in kilodaltons) are indicated on the left.
Fractions that contained antigenic activity for clones depicted in Fig. 1 are
indicated with a plus at the top of the lane. Fraction 1 was not tested. The arrow
on the right indicates a 43-kDa band common to FPLC fractions with stimulatory
activity for the Th clones in group III.
FIG. 3. Proliferative responses of three Th clones representative of three
antigenic groups to B. bovis Mexico HSS antigen fractionated by gel filtration.
HSS was applied to the Superose 12 column, eluted with PBS, and monitored for
protein at 280 nm (wavy line) on a scale of 0 (baseline) to 1.0 (maximum peaks)
U of absorbance. Fractions (25-ml samples) were assayed in duplicate cultures
with the following Th-cell clones and autologous APC: group III clone
C15.2G10, group V clone C15.1D10, and group IV clone C15.1H6 (plus 2%
[vol/vol] bovine TCGF). The symbols indicate the proliferative responses to
individual fractions. The mean 6 SD background proliferative responses for
clones C15.2G10 and C15.1D10 cultured with medium alone were 350 6 54 and
367 6 14 cpm, respectively. The mean 6 SD background proliferative response
for clone C15.1H6 cultured with medium plus TCGF was 271 6 23 cpm. The
relative retention times of the protein standards (in kilodaltons) and the void
volume (Vo) are indicated at the top of the figure.
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peak that eluted in the column void volume and a minor
antigenic peak (2,341 6 300 cpm as compared with a back-
ground proliferation of 367 6 14 cpm) that eluted with an
approximate size of 60 kDa. These data are consistent with the
recognition of unique antigens by the Th clones representative
of groups III, IV, and V and with the recognition of a common
antigen by the three clones in group III.
Fractionation of merozoite antigen by CFE. Both anion-
exchange chromatography and gel filtration methods of frac-
tionating parasite antigens are limited to the use of soluble
antigen and by the presence of numerous protein bands
present in many of the antigenic fractions when analyzed by
SDS-PAGE (Fig. 2) (12). These two drawbacks were partially
overcome by the use of a preparative CFE apparatus. B. bovis
merozoite CM antigen was fractionated by electrophoresis un-
der reducing conditions on a 15% acrylamide gel. Analysis of
every 10th fraction by SDS-PAGE and silver staining revealed
a step-wise progression of bands ranging from 14 to 25 kDa
(Fig. 4A). Th-cell lines, which proliferated against babesial
antigens but not URBC (data not shown), were tested for
proliferation against each fraction. Several peaks of activity
were revealed (Fig. 5). The Th-cell line from animal C97 pro-
liferated maximally against fractions containing antigens of
,14, 22, and 24 kDa, and the cell line derived from animal C15
proliferated against fractions containing antigens of ,14 and
16.5 kDa.
To resolve a broader spectrum of proteins, 10% acrylamide
gels were used in two experiments for fractionating merozoite
antigens by CFE. Analysis of every 10th fraction by SDS-
PAGE again revealed a step-wise progression of bands, rang-
ing from 20 to 95 kDa. The results from experiment 1 are
shown in Fig. 4B. When the C97 T-cell line was tested for
proliferation against fractions from these latter two experi-
ments, numerous peaks of antigenic activity were detected, and
stimulatory fractions contained antigens that ranged in appar-
ent molecular mass from 29 to 70 kDa (experiment 1) and 20
to 76 kDa (experiment 2) (Fig. 6). Many stimulatory fractions
that contained antigens of the same apparent sizes were de-
tected in the two CFE experiments.
To verify that the Th cells were stimulated by parasite pro-
teins in an MHC-restricted manner and were not activated to
proliferate by potential merozoite superantigens, stimulatory
fractions from the 15% acrylamide gel were retested for stim-
ulation of C97 T cells in the presence of either autologous APC
or allogeneic APC obtained from animal C15 which do not
present antigen to C97 T cells (5). In the presence of allogeneic
APC, no proliferation was detected against either CM or CFE
fractions, whereas TCGF still induced proliferation. For exam-
ple, when comparing proliferative responses (mean cpm6 SD)
of the T-cell line with autologous versus allogeneic APC, the
following results were obtained with the indicated antigens: B.
bovis CM, 109,000 6 1,954 versus 28 6 3; CFE fraction 36,
20,0116 608 versus 186 18; CFE fraction 107, 28,6106 4,728
versus 176 1 cpm; TCGF, 29,5086 1,691 versus 18,8276 983.
Since the responder C97 T-cell line consisted of 98% CD41 T
cells, the antigen-driven proliferative responses against the CM
fraction of B. bovis as well as all CFE fractions tested were
apparently MHC class II restricted.
We next tested Th clones representative of five different
antigenic groups (I, III, IV, V, and VII) for proliferation
against homogenized B. bovis merozoite antigen fractionated
by CFE. Most clones were tested on fractions obtained from
two separate CFE experiments. Individual fractions with peak
activity were analyzed on silver-stained SDS-polyacrylamide
gels to determine the apparent molecular masses of the anti-
gens in the fractions. As shown in Fig. 7, clones representative
of the different antigenic groups expressed unique antigenic
profiles when tested on the CFE fractions separated by elec-
FIG. 4. SDS-PAGE and silver staining analysis of merozoite antigens fractionated by CFE. (A) Merozoite CM antigen was fractionated by CFE with a 15%
acrylamide gel, and 30 ml of every 10th fraction or 25 mg of the CM used for fractionation was visualized on the stained analytical gel. (B) Merozoite H was fractionated
by CFE with a 10% acrylamide gel, and 37.5 ml of every 10th fraction or 25 mg of the H used for fractionation was visualized on the stained gel. Individual fraction
numbers, CM, or H are indicated at the top of each figure, and the relative mobilities of molecular mass standards (lane M) are indicated on the left of each panel
(in kilodaltons).
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trophoresis with 10% acrylamide gels. Interestingly, clones
C97.2D2 and C97.2E4 from antigenic group I had superimpos-
able antigenic profiles and recognized two major antigenic
activity peaks (Fig. 7A and B) corresponding to fractions that
contained antigens of 29 and 51 to 52 kDa. In experiment 2,
clone C15.2E4 again responded strongly to fractions contain-
ing 51-kDa antigens and to a high-molecular-mass antigen
ranging from 85 to 95 kDa, but there was no activity associated
with lower-molecular-mass antigens (data not shown). Clones
C97.3C3 and C15.2G10, representative of antigenic group III,
also displayed nearly identical antigenic profiles in this exper-
iment. Maximum proliferation was obtained with fraction 31
(Fig. 7C and D), which contained an antigen of 40 kDa. In the
second CFE experiment, an antigenic peak was observed when
clone C15.2G10 was stimulated with fraction 52, which again
contained a 40-kDa antigen (data not shown). Clone C15.1H6
(antigenic group IV) recognized antigen with maximal activity
in fraction 1 (Fig. 7E), which contained several bands of ap-
proximately 20 kDa. To verify the size of the antigen recog-
nized by this clone, C15.1H6 was tested against B. bovis CM
fractionated with a 15% acrylamide gel, which separated pro-
teins of #25 kDa (Fig. 4A). In this experiment, maximum
antigenic activity was obtained with fraction 89 (Fig. 7F), which
contained antigens of approximately 20 kDa. Clone C15.1D10
recognized a unique antigenic activity peak in fraction 85 that
contained a 58-kDa antigen (Fig. 7G). This antigenic profile
FIG. 5. Proliferative responses of B. bovis-specific Th cell lines to B. bovisMexico CM antigen fractionated by CFE. CM was solubilized in SDS-sample buffer and
electrophoresed on a 15% acrylamide gel. Proteins were eluted from the gel and collected as 2.5-ml fractions. Proteins in 1.0 ml of each fraction were precipitated and
resuspended in PBS, and 12.5-ml samples were assayed in duplicate cultures for stimulation of T-cell lines from animal C97 (A) or C15 (B). Mean 6 SD background
proliferative responses for C97 and C15 T-cell lines cultured with medium alone were 80 6 60 and 245 6 35 cpm, respectively.
FIG. 6. Proliferative responses of B. bovis-specific C97 T-cell line to B. bovis Mexico H antigen fractionated by CFE. H was solubilized in SDS-sample buffer and
electrophoresed on a 10% acrylamide gel in two experiments. Proteins were eluted from the gel and collected as 2.5-ml fractions. Proteins in 1.0 ml (experiment 1)
or 1.5 ml (experiment 2) were precipitated and resuspended in PBS, and 12.5-ml (experiment 1) (A) or 6.2-ml (experiment 2) (B) samples were assayed in duplicate
cultures for stimulation of the C97 T-cell line described in the legend to Fig. 5. The apparent molecular masses (in kilodaltons) of molecules present in fractions
stimulating peak proliferative responses are indicated by arrows. Mean 6 SD background proliferative responses for the T-cell line in experiments 1 and 2 cultured
with medium alone were 832 6 36 and 4,057 6 923 cpm, respectively.
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was also verified in the second CFE experiment, wherein frac-
tion 100, which contained antigens of approximately 60 kDa,
evoked peak proliferation of this clone (data not shown). Fi-
nally, clone C15.2D7, tested against CFE fractions from the
second fractionation experiment, detected three activity peaks
corresponding to fractions containing antigens of approxi-
mately 38, 42, and 83 kDa (Fig. 7H). These results are sum-
marized in Table 2.
Specificity of rabbit antisera produced against CFE frac-
tions with peak activity for Th cells. Rabbits were immunized
with fractions containing maximum antigenic activity for Th
clones representative of the five different antigenic groups.
Antisera were then characterized for reactivity against homog-
enized B. bovis merozoites, and immunoblot analysis was per-
formed with B. bovismerozoite antigen obtained from infected
erythrocytes or uninfected erythrocytes from the same animal
used for merozoite culture (Fig. 8). There was no reactivity of
preimmunization sera diluted 1:20 to 1:800 with either anti-
genic preparation (data not shown). Antisera from immunized
rabbits recognized parasite-specific bands, as shown in Fig. 8
and summarized in Table 2. Results with antisera produced
against CFE fractions from experiment 1 are shown in Fig. 8A.
The antiserum produced against fraction 1, which contained
antigens of approximately 20 kDa that stimulated clone 1H6,
recognized a unique 20-kDa band. The antiserum raised
against fractions 30 plus 31, which contained antigens of ap-
proximately 40 kDa, recognized a 40-kDa band, supporting our
hypothesis that the antigen recognized by clones representative
of group III is approximately 40 kDa. Antiserum produced
against the 29-kDa protein(s) present in fraction 11 recognized
a 29- to 30-kDa doublet and did not bind to larger molecules
on the blots. Immunization with fractions 60 plus 61, which
FIG. 8. Immunoblot analysis of rabbit antisera produced against Th-cell-
immunostimulatory CFE fractions. Rabbits were immunized with 10% acryl-
amide CFE fractions from experiment 1 (fractions 1 and 11, a pool of fractions
30 and 31, and a pool of fractions 60 and 61 [A]) or with 10% CFE fractions from
experiment 2 (fraction 40, 59, or 100 [B]). The fraction(s) used for immunization
is indicated at the bottom of each panel. Following adsorption of the antisera
with URBC membranes, sera were diluted 1:800 or 1:1,600 (fraction 100) and
used to probe either B. bovis Mexico merozoites prepared from infected eryth-
rocyte cultures (I) or control, uninfected erythrocytes used to cultivate the
merozoites (U), after electrophoresis of 20 and 25 mg of protein per lane,
respectively, on 12% acrylamide gels and transfer to nitrocellulose. The relative
mobilities (M) of the molecular mass standards (in kilodaltons) are indicated on
the left of each panel.
TABLE 2. Apparent molecular masses of proteins fractionated by
CFE that were recognized by B. bovis-specific Th-cell clones and
by rabbit antisera produced against stimulatory CFE fractions
Th-cell clone
Apparent molecular mass(es) (kDa)
of merozoite antigens in CFE
fractions recognized by:
Th-cell proliferation
a
Rabbit antiserab
Group I
Expt 1
C97.2E4 29, 51–52 29, 43, 95
C97.2D2 29, 51–52
Expt 2: C97.2E4 51, 85–95
Group III
C15.1G10 40 40
C97.3C3 40
Group IV: C15.1H6 20 20
Group V: C15.1D10 58–60 60
Group VII: C15.2D7 38, 45, 83 38, 42–44, 54
a Fractions obtained by CFE with 10% acrylamide gels in two experiments
were tested for stimulation of the indicated Th-cell clones. The apparent mo-
lecular masses (in kilodaltons) of antigens present in fractions with maximal
stimulatory activity for a given clone were determined by analysis of silver-
stained SDS-polyacrylamide gels and comparison with molecular mass standards.
b Antisera were raised in rabbits against individual CFE fractions that induced
maximal proliferation of the indicated Th-cell clones. The antisera were tested
on immunoblots against a homogenate of B. bovis merozoites, and the apparent
molecular masses (in kilodaltons) of bands recognized by the antisera were
determined by comparison with molecular mass standards.
FIG. 7. Proliferative responses of B. bovis-specific Th-cell clones to B. bovisMexico H antigen fractionated by CFE. Th-cell clones were assayed in duplicate cultures
for proliferation against CFE fractions described in the legends to Fig. 6 and 7. The clones depicted in panels A to E and G were tested with 12.5 ml of CFE fractions
from the 10% acrylamide gel in experiment 1. Clone C15.1H6, depicted in panel F, was tested with 12.5 ml of CFE fractions from the 15% acrylamide gel. Clone
C15.2D7, depicted in panel H, was tested with 6.2 ml of CFE fractions from the 10% acrylamide gel in experiment 2. Mean 6 SD background proliferative responses
for the clones were as follows: (A) C97.2D2 with medium, 256 6 1; (B) C97.2E4 with medium, 164 6 25; (C) C97.3C3 with 1 U of human IL-2 per ml, 4,732 6 566;
(D) C15.2G10 with 2 U of human IL-2 per ml, 9,247 6 18; (E) C15.1H6 with 1 U of human IL-2 per ml, 34 6 14; (F) C15.1H6 with medium, 48 6 5; (G) C15.1D10
with 1 U of human IL-2 per ml, 2,597 6 523; (H) C15.2D7 with medium, 185 6 8. The results are presented as either mean cpm (A, B, E, F, and H) or the difference
(D) in mean cpm of cultures stimulated with CFE fractions minus the mean cpm of background responses (C, D, and G).
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contained 51- to 52-kDa proteins, produced an antiserum that
recognized 43- and 95-kDa antigens not present in URBC.
These data suggest that the 29- and 51- to 52-kDa antigens
present as activity peaks for clones of group I may be derived
from a larger molecule.
Results with antisera produced against CFE fractions from
experiment 2 are shown in Fig. 8B. Fractions 40, 59, and 156
stimulated clone C15.2D7. Immunization with fraction 40,
which contained a 38-kDa antigen, recognized two bands of 38
and 44 kDa. Immunization with fraction 59, which contained a
45-kDa antigen, reacted intensely with these two bands and a
42-kDa band and less intensely with additional larger bands.
Immunization with fraction 156, which contained antigen of
approximately 83 kDa, produced an antiserum that recognized
numerous high-molecular-mass bands but also recognized an
intense band of approximately 44 kDa (data not shown). These
results are consistent with the proliferation profile of this
clone, which responded to three activity peaks (38, 45, and 83
kDa). Immunization with fraction 100, which stimulated clone
C15.1D10 and contained a 58- to 60-kDa antigen, produced an
antiserum that was directed predominantly against a 60-kDa
band, although additional bands were detected.
DISCUSSION
Immunization with killed B. bovis merozoites or biochemi-
cally fractionated merozoite antigen has resulted in various
degrees of protective immunity against homologous and het-
erologous B. bovis challenge (19, 45, 50). One approach taken
to identify vaccine antigens of babesial parasites was to sys-
tematically fractionate parasite antigens by biochemical puri-
fication strategies, perform immunization trials with parasite
fractions, and raise monoclonal antibodies against fractions
with protective activity for the production of recombinant pro-
teins (19, 50, 51). It was found that serologically immuno-
dominant antigens isolated from protective parasite fractions
were not themselves protective (20, 45, 50, 51), whereas anti-
gens present in small quantities in the parasite that did not
induce strong antibody responses did confer some protection
(15, 16, 18, 19, 50, 51). These partially protective antigens
included a 38-kDa protein (designated 15B1 and subsequently
12D3), a 60- to 70-kDa protein with protease activity (desig-
nated T21B4) and shown recently to be identical to rhoptry
associated protein-1 (RAP-1) (15, 42), a high-molecular-weight
protein designated 11C5 (19), and a 77- to 80-kDa dextran-
sulfate-binding protein designated Bv80 (16) and previously
designated Bb-1 by our group (13, 22, 43, 47). Secreted para-
site EXOs, recovered from either plasma of infected cattle or
culture supernatants, have also been shown to protect cattle
against homologous and heterologous parasite challenge (36).
However, none of these antigens were characterized for the
ability to induce Th-cell responses in these studies.
A different approach that we have taken for the selection of
potential vaccine antigens of B. bovis was to use Th cells as
probes to identify antigens that elicit strong anamnestic re-
sponses, since Th cells are critical for the induction and main-
tenance of both humoral and cell-mediated immunity against
related protozoan parasites (8, 28, 41). Because the Th-cell
clones were derived from T-cell lines cultured for 3 to 6 weeks
with CM or soluble merozoite antigens, they are likely to
detect antigens that are immunodominant for T cells. The Th
clones used in this study were selected on the basis of strong
proliferative responses to antigen in the absence of exogenous
growth factor, and the majority were characterized previously
as being Th0 clones that expressed relatively high levels of
IFN-g (11, 12).
Previous attempts to identify T-cell-dependent B. bovis pro-
teins by biochemical fractionation methods revealed distinct
patterns of reactivity by Th-cell clones for membrane and sol-
uble forms of merozoite antigen as well as soluble anti-
gen fractionated by anion-exchange chromatography (12). The
present study was undertaken to define more precisely the
antigens that activated Th-cell clones that recognized distinct
epitopes. Gel filtration columns were able to resolve three
separate peaks of antigenic activity. However, as with anion-
exchange chromatography, this method can be used only with
soluble parasite antigens and was generally incapable of puri-
fying a single antigen. Furthermore, we were unable to detect
antigenic activity in Th-cell proliferation assays when HSS was
subjected to gel filtration and then to anion-exchange chroma-
tography. For these reasons, we applied the technique of CFE
to separate homogenized merozoite proteins. Although this
single-step procedure has not resulted in complete purification
of babesial merozoite antigens, it has enabled the tentative
identification of antigens with molecular masses ranging from
20 to 95 kDa that stimulate proliferation of Th-cell lines and
clones derived from cattle immune to challenge infection with
B. bovis.
Many of the same peaks of antigenic activity in merozoite
antigen fractionated by CFE and identified by a B. bovis-
specific T-cell line were identified subsequently by our panel of
Th-cell clones. This finding suggests that the clones, selected by
in vitro cultivation with unfractionated antigen, are represen-
tative of Th cells that proliferate against immunodominant
merozoite antigens in the bulk cultures. Clones assigned to
antigenic group I responded preferentially to parasite mem-
brane antigens, and CFE enabled the identification of several
peaks of antigenic activity which were identical for two clones,
C97.2D2 and C97.2E4. Since these clones were derived from
the same cell line, it is likely that they recognize the same
epitope, which appears to be derived from a high-molecular-
weight protein or may be shared by proteins of 51 to 52 and 95
kDa. These clones did not respond to either recombinant 42-
kDa merozoite surface antigen-1 (MSA-1) (7) or recombinant
77-kDa spherical body protein Bb-1 of B. bovis (9). Clones
assigned to antigenic group III appear to recognize an antigen
with an apparent molecular mass of 40 kDa, although analysis
of antigen fractionated by CFE revealed additional peaks of
activity in fractions with larger antigens. The lack of reactivity
of antiserum produced against the peak fraction with larger
molecules suggests that the promiscuous T-cell response is not
due to degradation of a larger molecule. However, the possi-
bility that a 40-kDa fragment derived from a larger protein
contains Th-cell epitopes but not B-cell epitopes antigenic for
rabbits cannot be ruled out at this time. An alternative expla-
nation for the response of group III clones to more than one
antigenic peak is that the T-cell epitope is shared by more than
one polypeptide. This possibility is consistent with the broad
peak of activity that eluted from the gel filtration column and
the broad specificity of these clones when tested against dif-
ferent babesial isolates and species. Clones in group III did not
respond to 42-kDa MSA-1, 60-kDa RAP-1, or 77-kDa Bb-1
recombinant proteins of B. bovis (9). Clone C15.1H6, which is
the only Th-cell clone assigned to group IV, appears to recog-
nize a 20-kDa antigen. Clone C15.1D10, which is the only
Th-cell clone assigned to group V, appears to recognize a 58-
to 60-kDa protein. Although the majority of activity eluted
from the FPLC gel filtration column in the void volume, a
small peak of activity which eluted just after the 66-kDa stan-
dard was detected. In two experiments using CFE and 10%
acrylamide gels, peak immunostimulatory activity for this clone
was obtained with fractions containing 58- to 60-kDa proteins.
3114 BROWN ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
Antiserum raised against one of these fractions recognized
several bands, with a predominant band of 60 kDa. This clone
does not respond to the 60-kDa RAP-1 protein of B. bovis (9).
Finally, clone C15.2D7, representative of group VII, appears
to recognize a 44-kDa antigen. This clone responded to three
major antigenic activity peaks when B. bovis was fractionated
by CFE. Rabbit antisera raised against fractions representative
of the three peaks all recognized a 44-kDa band, whereas sera
produced against the smaller 38- and 45-kDa antigens did not
recognize higher-molecular-mass antigens on immunoblots.
These data suggest, but do not prove, that the immunogenic
T-cell activity detected as three peaks is not due to degraded
forms of a larger molecule. Clone C15.2D7 did not proliferate
against the 77-kDa Bb-1 protein or the 42-kDa MSA-1 protein
(9), ruling out this major antigenic component as the target of
recognition by this Th-cell clone. However, a related 44-kDa
merozoite surface antigen (MSA-2), which is coexpressed with
the 42-kDa MSA-1 antigen on the Mexico and Texas isolates
of B. bovis, has also been described. The genes encoding
MSA-1 and MSA-2 and the Australia BabR genes appear to be
members of a multigene family (23, 24). The reactivity of clone
C15.2D7 with both the Mexico and Texas but not the Australia
isolates of B. bovis is consistent with potential recognition of
the MSA-2 protein which expresses antibody epitopes and
gene sequences that are highly conserved between the Mexico
and Texas isolates but either less conserved or absent from the
Australia isolates (24, 37).
The identification of antigens immunostimulatory for the
Th-cell clones described in this study will be verified by use of
the rabbit antisera to isolate DNA clones encoding these pro-
teins from a B. bovis expression library (47). Recombinant
antigens will be assessed for immunogenicity for the Th-cell
clones and T-cell lines from the animals used in this study as
well as for Th-cell lines derived from additional B. bovis-im-
mune cattle. Furthermore, it will be important to define the
cytokines expressed by both Th cells and APC in response to
recombinant antigens, both in vitro and in vivo. Studies with B.
bovis-specific Th-cell clones derived by stimulation with unfrac-
tionated merozoite antigens revealed a predominant Th0 cy-
tokine profile among a panel of 20 clones, with coexpression of
IL-4 and IFN-g mRNA and expression of high titers of IFN-g
by the majority of clones. However, the use of crude merozoite
antigens to select memory cells in vitro and the use of TCGF,
which likely contains IL-4 in addition to IL-2, to maintain the
Th clones may have influenced the profile of cytokines ex-
pressed in favor of an unrestricted profile (29, 38). In limited
studies where the cytokine profiles of Th clones selected with
recombinant antigens have been examined, we did obtain ev-
idence for a more restricted profile. For example, clones se-
lected by and reactive with recombinant 77-kDa antigen Bb-1
expressed Th1 cytokines IL-2 and IFN-g but not IL-4 (13).
Recent studies also demonstrated expression of Th1 cytokines
by 9 of 12 Mycobacterium tuberculosis purified protein deriva-
tive-specific bovine Th clones (2). Since cytokines such as IL-10
and IL-12 expressed by APC also influence Th-cell subset
differentiation and cytokine expression by differentiated hu-
man (17, 34, 35) and bovine (2, 10) T cells, it will be important
to examine the immunomodulatory effects of recombinant an-
tigens, selected by their immunostimulatory properties for Th
cells, on APC. A comprehensive study of the nature of the
T-cell and macrophage responses to defined antigens selected
by T-cell immunogenicity both in vitro and in vivo combined
with eventual testing of recombinant antigens in vaccine trials
will help elucidate the mechanisms of acquired resistance to B.
bovis and other hemoparasites.
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